Male Circumcision Clinical Trial
Official title:
Cluster-randomized Study of Church-Based Intervention to Promote Male Circumcision in Tanzania
Male circumcision has been demonstrated by three randomized trials to be a highly effective
method of HIV prevention, leading the World Health Organization to recommend its widespread
implementation. The investigators' prior work in Tanzania has shown that the acceptability
and uptake of male circumcision depends highly on religious beliefs. The investigators
hypothesize that the uptake of male circumcision can be increased in villages in which male
circumcision is offered in conjunction with church-based teaching and practice, compared
with villages in which male circumcision is not promoted through churches.
The investigators will conduct a community randomized trial in rural Tanzania, where the
government is systematically providing free male circumcision via campaigns in villages in
which rates of circumcision are low. Prior to the start of the campaign, villages will be
randomized to receive or not to receive church-based and culturally-informed promotion of
male circumcision. All villages will receive the standard non-church-based health education
that accompanies male circumcision campaigns.
The investigators will compare rates of male circumcision, both by self-report and by
demographic data collected at the time of circumcision, among men and boys before and after
the campaign in intervention villages with church involvement versus control villages
without church involvement.
The investigators will conduct a mixed-methods study that will include a community cluster
randomized trial, followed by focus group discussions in both intervention and control
villages after completion of the trial. This trial will be performed in 16 villages in
conjunction with a voluntary medical male circumcision outreach campaign that is being
offered by the Tanzanian Ministry of Health in the northwest of the country. The campaign
brings a team of clinicians to perform free male circumcisions in 2-3 villages at a time.
The campaign routinely provides male circumcision and voluntary HIV counseling and testing
to between one hundred to two hundred men per day and typically remains in a village for 3-6
weeks until demand for circumcision decreases.
The unit of randomization in the cluster randomized trial will be the village. The
investigators will work in partnership with the male circumcision outreach campaign to
identify eligible village pairs that are located within 60 kilometers of one another and
will be targeted by the male circumcision outreach campaign at the same time. The
investigators believe that the geographic proximity of the paired villages and the start
date of the male circumcision outreach campaign in the village will be the two most
important factors affecting uptake of male circumcision in the villages. The geographic
proximity is important for the assumption that baseline rates of male circumcision and other
village characteristics are likely similar. The start date of the campaign is important
because: (1) uptake of male circumcision is likely to be higher during the dry season, when
there is less farming work for men to do, and (2) the investigators predict that uptake of
male circumcision may increase over time as more and more men are circumcised in the Mwanza
region and it increasingly becomes a societal norm.
The investigators will restrict our inclusion criteria to rural villages that have clear
boundaries so that the male population is stable without influx as would be common in an
urban area. In these rural regions, dirt roads and poor infrastructure lead to minimal
contact between villages so it is predicted that little information will be shared between
intervention and control villages.
Both intervention and control villages will receive the standard community outreach events
to promote male circumcision that are provided by the Tanzanian Ministry of Health during
their male circumcision outreach campaign. This may include community meetings, public
education sessions by health care workers, drama, broadcast announcements by cars with
megaphones, and distribution of health informational brochures. However, the standard
education does not work specifically with religious leaders. Among the members of the male
circumcision outreach team, only one clinician, who will provide medical teaching at the
educational seminar for religious leaders, will be aware of a village's assignment as an
intervention or control group.
The additional intervention that will be given to villages that are randomized to receive
the intervention will be a one-day educational seminar for church leaders of that village.
The seminar will focus on male circumcision and will address religious, cultural, and health
implications of this practice. It will also provide teaching and tools for church leaders to
use in discussing male circumcision with their congregations.
After the completion of the male circumcision outreach campaign in a village, our study team
will enroll individual church leaders. Leaders from both intervention and control villages
will participate in separate groups and will be led in a discussion of their perceptions of
male circumcision. Church leaders, who will be invited from a variety of denominational
backgrounds, will provide written informed consent for participation in the focus group
discussions.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01247844 -
Evaluation of Healing at Three Time Intervals and Potential for Spontaneous Detachment
|
N/A | |
Completed |
NCT02242565 -
Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia
|
N/A | |
Completed |
NCT00993811 -
The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
|
Phase 1 | |
Completed |
NCT02281435 -
Follow Up Study to Evaluate a Non-Surgical Device for Adult Male Circumcision for Screen Failure Subjects
|
N/A | |
Completed |
NCT04263064 -
High Volume Caudal Study
|
Early Phase 1 | |
Completed |
NCT02091726 -
Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive
|
N/A | |
Completed |
NCT02309710 -
Male Circumcision (MC) Using the ShangRing™ Device in Malawi
|
Phase 1 | |
Completed |
NCT01150370 -
A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
|
N/A | |
Completed |
NCT01434628 -
Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Non-Surgical Circumcision When Performed by Nurses
|
N/A | |
Active, not recruiting |
NCT03914365 -
Pudendal Nerve Block vs Penile Nerve Block for Analgesia During Pediatric Circumcision
|
N/A | |
Completed |
NCT01921608 -
Safety Study of the PrePex Device for Non-Surgical Adult Male Circumcision During Phased in National Implementation in an Effort to Prevent the Spread of HIV
|
N/A | |
Completed |
NCT03634358 -
Bipolar Scissors for Circumcision
|
N/A | |
Completed |
NCT02277795 -
Evaluation of the AccuCirc for Early Infant Male Circumcision in Nyanza, Kenya
|
N/A | |
Completed |
NCT01567436 -
A Prospective Field Study: Introducing the Shang Ring in Routine Clinical Settings
|
Phase 4 | |
Completed |
NCT03223532 -
Randomized Trial Comparing PrePex Day 7 Foreskin Removal Procedure (FRP) to a Day 0 PrePex FRP .
|
N/A |